Methods of treatment utilizing certain melatonin derivatives

Details for Australian Patent Application No. 2006230530 (hide)

Owner Phase 2 Discovery

Inventors Zemlan, Frank P.

Agent Cullen & Co

Pub. Number AU-A-2006230530

PCT Pub. Number WO2006/105455

Priority 60/666,954 31.03.05 US; 11/384,772 20.03.06 US

Filing date 30 March 2006

Wipo publication date 5 October 2006

International Classifications

A61K 31/4045 (2006.01)

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

1 November 2007 PCT application entered the National Phase

  PCT publication WO2006/105455 Priority application(s): WO2006/105455

8 May 2008 Assignment before Grant

  Phase 2 Discovery The application has been assigned to Phase 2 Discovery, Inc.

11 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006230531-Process for removing color bodies from hydrocarbon-based fuels using activated carbon

2006230517-Spirocyclic heterocyclic derivatives and methods of their use